In 2023, the trade exchange (includes international purchases and sales) of Vitamin C and its Derivatives Used Primarily as Vitamins was US$21.2M.
In 2023, the states with the most international sales in Vitamin C and its Derivatives Used Primarily as Vitamins were Jalisco (US$533k), Ciudad de México (US$124k), Estado de México (US$37k), and Nuevo León (US$16.1k).
The states with the most international purchases in 2023 were Jalisco (US$11.9M), Ciudad de México (US$3.84M), Estado de México (US$1.73M), Querétaro (US$1.21M), and Puebla (US$362k).
In 2023, the main commercial destinations of Vitamin C and its Derivatives Used Primarily as Vitamins were Haiti (US$214k), Barbados (US$110k), Costa Rica (US$79.4k), Guatemala (US$67.6k), and Dominican Republic (US$57.1k).
The main commercial origins of Vitamin C and its Derivatives Used Primarily as Vitamins in 2023 were China (US$12.7M), United Kingdom (US$4.14M), France (US$1.04M), United States (US$367k), and Taiwan (Republic of China) (US$366k).
In the global context, the main exporting countries of Vitamin C and its Derivatives Used Primarily as Vitamins in 2022 were China (US$943M), United Kingdom (US$173M), and Netherlands (US$103M). In the same year, the main importing countries of Vitamin C and its Derivatives Used Primarily as Vitamins were United States (US$252M), Germany (US$138M), and Japan (US$92M).